<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>Robotic-Biomanufacturing-Cell-Line on Bioecon</title><link>https://en.bioecon.ru/technologies/robotic-biomanufacturing-cell-line/</link><description>Recent content in Robotic-Biomanufacturing-Cell-Line on Bioecon</description><generator>Hugo</generator><language>en-US</language><lastBuildDate>Wed, 19 Aug 2026 15:43:34 +0700</lastBuildDate><atom:link href="https://en.bioecon.ru/technologies/robotic-biomanufacturing-cell-line/index.xml" rel="self" type="application/rss+xml"/><item><title>Automated cell culture systems</title><link>https://en.bioecon.ru/technology/automated-cell-culture-systems/</link><pubDate>Wed, 19 Aug 2026 00:00:00 +0000</pubDate><guid>https://en.bioecon.ru/technology/automated-cell-culture-systems/</guid><description>Robotic and software platforms that automate the closed, GMP-grade cell culture and manufacturing steps behind cell and gene therapies — end-to-end automated manufacturing platforms, robotic drug-product handling, and the scheduling/orchestration software coordinating multi-instrument automated workflows — sold by four specialists (Cellares, Multiply Labs, Ori Biotech, HighRes Biosolutions) targeting the labor-intensive, variability-prone manual cell-therapy manufacturing process.</description></item></channel></rss>